2 Safety
8
n
Comply with the relevant standards and directives applicable to the reprocessing and sterilization of
textiles and instruments (in Germany e.g. from the RKI and DGSV).
n
Only ever use packaging material and systems which have been cleared by their manufacturer for
steam sterilization.
Program abort
n
Please observe that depending on the time of the program abort, opening the door following a pro-
gram abort can lead to hot steam leaving the sterilization chamber.
n
Depending on the time of the program abort, it is possible that the load is unsterile. Observe the clear
instructions shown on the display of the device. Sterilize the affected load after re-wrapping again.
Removing the sterile material
n
Never use force to open the door.
n
Use a tray lifter to remove the tray. Never touch the sterilized equipment, the chamber, the mount or
the inside of the door with bare hands. The components are hot.
n
Check the packaging on the sterile material for damage when removing it from the steam sterilizer.
Should the packaging be damaged, re-pack the load and re-sterilize it.
Transport and storage
n
Store and transport the device in a frost-free environment.
n
The device should always be carried by two people.
n
Use suitable carrying straps to carry the device.
Maintenance
n
Maintenance should only be performed by authorised technicians.
n
Maintain the specified servicing intervals.
n
Only original MELAG spare parts may be used.
Repair
n
Never open the device housing. Incorrect opening and repair can compromise electrical safety and
pose a danger to the user. The device may only be opened by an authorised technician who must be
a qualified electrician.
Malfunctions
n
Should the device issue the same malfunction message repeatedly, turn off the device and if neces-
sary, inform your stockist.
n
The device may only be serviced by authorised technicians.
Notification requirement in the event of serious accidents in the European Economic Area
n
Please note that all serious accidents which occur in connection with the medical product (e.g. death
or serious deterioration in the state of health of a patient) which were presumably caused by the pro-
duct, must be reported to the manufacturer (MELAG) and the relevant authority of the member state,
in which the user and/or patient resides.